{"id":"https://openalex.org/W7225311430","doi":"https://doi.org/10.5281/zenodo.23975251","title":"Evolution Of Drug Safety Surveillance in India: A Review of Government Policies, Reporting systems, And Regulatory Actions on Adverse Drug Reactions","display_name":"Evolution Of Drug Safety Surveillance in India: A Review of Government Policies, Reporting systems, And Regulatory Actions on Adverse Drug Reactions","publication_year":2026,"publication_date":"2026-11-05","ids":{"openalex":"https://openalex.org/W7225311430","doi":"https://doi.org/10.5281/zenodo.23975251"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.23975251","doi":"https://doi.org/10.5281/zenodo.23975251","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23975251","pdf_url":null,"source":{"id":"https://openalex.org/S5407000610","display_name":"International Journal of Pharmaceutical Research and Applications","issn_l":"2456-4494","issn":["2456-4494"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.5281/zenodo.23975251","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160884347","display_name":"J. kumbhar Prof. Sachin.","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Prof. Sachin., J. kumbhar","raw_affiliation_strings":["Assistant Professor, Fabtech College of Pharmacy, Sangola"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Assistant Professor, Fabtech College of Pharmacy, Sangola","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159518052","display_name":"K. Bais Dr.Sanjay.","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dr.Sanjay., K. Bais","raw_affiliation_strings":["Principal and Professor, Fabtech College of Pharmacy, Sangola"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Principal and Professor, Fabtech College of Pharmacy, Sangola","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5160786608","display_name":"T. Chaudhari Pranjali.","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pranjali., T. Chaudhari","raw_affiliation_strings":["Student, Fabtech College of Pharmacy, Sangola"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Student, Fabtech College of Pharmacy, Sangola","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.921999990940094},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8119999766349792},{"id":"https://openalex.org/keywords/pharmacovigilance-programme-of-india","display_name":"Pharmacovigilance Programme of India","score":0.9769999980926514},{"id":"https://openalex.org/keywords/drug-regulation","display_name":"drug regulation","score":0.5540000200271606},{"id":"https://openalex.org/keywords/adverse-drug-reaction-reporting","display_name":"adverse drug reaction reporting","score":0.8679999709129333},{"id":"https://openalex.org/keywords/underreporting","display_name":"underreporting","score":0.6850000023841858},{"id":"https://openalex.org/keywords/drug-prohibition","display_name":"drug prohibition","score":0.4490000009536743},{"id":"https://openalex.org/keywords/safety-warnings","display_name":"safety alerts","score":0.8209999799728394},{"id":"https://openalex.org/keywords/materiovigilance","display_name":"materiovigilance","score":0.7139999866485596},{"id":"https://openalex.org/keywords/hemovigilance","display_name":"hemovigilance","score":0.9990000128746033}],"concepts":[{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.90829998254776},{"id":"https://openalex.org/C2778137410","wikidata":"https://www.wikidata.org/wiki/Q2732820","display_name":"Government (linguistics)","level":2,"score":0.6705999970436096},{"id":"https://openalex.org/C2993432071","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug reaction","level":3,"score":0.5182999968528748},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5065000057220459},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.5030999779701233},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4618000090122223},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.44999998807907104},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.39570000767707825},{"id":"https://openalex.org/C2777488183","wikidata":"https://www.wikidata.org/wiki/Q6900510","display_name":"Safety monitoring","level":2,"score":0.38499999046325684},{"id":"https://openalex.org/C2780542314","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug reaction","level":3,"score":0.3758000135421753},{"id":"https://openalex.org/C206345919","wikidata":"https://www.wikidata.org/wiki/Q20380951","display_name":"Resource (disambiguation)","level":2,"score":0.3580999970436096},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.3504999876022339},{"id":"https://openalex.org/C545542383","wikidata":"https://www.wikidata.org/wiki/Q2751242","display_name":"Medical emergency","level":1,"score":0.3330000042915344},{"id":"https://openalex.org/C197636746","wikidata":"https://www.wikidata.org/wiki/Q7234359","display_name":"Postmarketing surveillance","level":3,"score":0.328900009393692},{"id":"https://openalex.org/C2779328685","wikidata":"https://www.wikidata.org/wiki/Q1475557","display_name":"Patient safety","level":3,"score":0.32850000262260437},{"id":"https://openalex.org/C39549134","wikidata":"https://www.wikidata.org/wiki/Q133080","display_name":"Public relations","level":1,"score":0.3221000134944916},{"id":"https://openalex.org/C2991908516","wikidata":"https://www.wikidata.org/wiki/Q1639780","display_name":"Regulatory authority","level":2,"score":0.3158999979496002},{"id":"https://openalex.org/C2777351106","wikidata":"https://www.wikidata.org/wiki/Q49371","display_name":"Legislation","level":2,"score":0.3034999966621399},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.30160000920295715},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.26829999685287476},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.2671000063419342},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.26579999923706055},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.2515000104904175}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.23975251","doi":"https://doi.org/10.5281/zenodo.23975251","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23975251","pdf_url":null,"source":{"id":"https://openalex.org/S5407000610","display_name":"International Journal of Pharmaceutical Research and Applications","issn_l":"2456-4494","issn":["2456-4494"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.5281/zenodo.23975252","doi":"https://doi.org/10.5281/zenodo.23975252","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23975252","pdf_url":null,"source":{"id":"https://openalex.org/S5407000610","display_name":"International Journal of Pharmaceutical Research and Applications","issn_l":"2456-4494","issn":["2456-4494"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.5281/zenodo.23975251","doi":"https://doi.org/10.5281/zenodo.23975251","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23975251","pdf_url":null,"source":{"id":"https://openalex.org/S5407000610","display_name":"International Journal of Pharmaceutical Research and Applications","issn_l":"2456-4494","issn":["2456-4494"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4417429422","https://openalex.org/W7204960206","https://openalex.org/W7216087727","https://openalex.org/W4416779934","https://openalex.org/W7154738646","https://openalex.org/W4411970184","https://openalex.org/W2895635130","https://openalex.org/W7215702067","https://openalex.org/W7155511532","https://openalex.org/W4414194667"],"abstract_inverted_index":{"Drug":[0],"safety":[1,19,132,184],"surveillance":[2],"in":[3,32,39,50,62,186],"India":[4,60],"has":[5],"changed":[6],"considerably":[7],"over":[8],"the":[9,28,33,40,43,46,56,65,77,82,91,118],"past":[10],"five":[11],"decades,":[12],"shaped":[13],"by":[14],"public":[15],"health":[16],"needs,":[17],"global":[18],"events,":[20],"and":[21,52,79,85,90,95,115,131,156,169,181],"growing":[22],"regulatory":[23],"capacity.":[24],"This":[25],"review":[26,160],"traces":[27],"development":[29],"of":[30,45,59,93],"pharmacovigilance":[31],"country,":[34],"from":[35],"early":[36],"pilot":[37],"efforts":[38],"1980s":[41],"to":[42,76,176],"establishment":[44],"National":[47],"Pharmacovigilance":[48,57],"Programme":[49,58],"2004":[51],"its":[53],"relaunch":[54],"as":[55,126],"(PvPI)":[61],"2010":[63],"under":[64],"Indian":[66],"Pharmacopoeia":[67],"Commission.":[68],"It":[69],"examines":[70],"key":[71],"policy":[72],"milestones,":[73],"including":[74,146],"amendments":[75],"Drugs":[78,84],"Cosmetics":[80],"Rules,":[81,88],"New":[83],"Clinical":[86],"Trials":[87],"2019,":[89],"introduction":[92],"Materiovigilance":[94],"Haemovigilance":[96],"programmes.":[97],"The":[98,159],"reporting":[99,110],"infrastructure":[100],"is":[101],"discussed,":[102],"covering":[103],"adverse":[104],"drug":[105,127,183],"reaction":[106],"monitoring":[107],"centres,":[108],"voluntary":[109],"tools,":[111],"mobile":[112],"applications,":[113],"helplines,":[114],"integration":[116],"with":[117],"WHO":[119],"Uppsala":[120],"Monitoring":[121],"Centre.":[122],"Regulatory":[123],"actions,":[124],"such":[125],"bans,":[128],"label":[129],"changes,":[130],"alerts,":[133],"are":[134,144,174],"evaluated":[135],"for":[136],"their":[137],"effect":[138],"on":[139],"clinical":[140],"practice.":[141],"Persistent":[142],"challenges":[143],"highlighted,":[145],"underreporting,":[147],"limited":[148],"awareness":[149],"among":[150,172],"healthcare":[151],"professionals,":[152],"uneven":[153],"data":[154],"quality,":[155],"resource":[157],"gaps.":[158],"concludes":[161],"that":[162],"stronger":[163],"training,":[164],"digital":[165],"reporting,":[166],"patient":[167],"participation,":[168],"closer":[170],"coordination":[171],"stakeholders":[173],"essential":[175],"build":[177],"a":[178],"more":[179],"responsive":[180],"reliable":[182],"system":[185],"India.":[187]},"counts_by_year":[],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2026-11-06T00:00:00"}